UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 172

Sortiert nach

Impact of IDH1 R132 Mutations and an IDH1 Single Nucleotide Polymorphism in Cytogenetically Normal Acute Myeloid Leukemia: SNP rs11554137 Is an Adverse Prognostic Factor

Journal of clinical oncology, 2010-05, Vol.28 (14), p.2356-2364

2010

Volltextzugriff (PDF)

Condensed versus standard schedule of high-dose cytarabine consolidation therapy with pegfilgrastim growth factor support in acute myeloid leukemia

Blood cancer journal (New York), 2017-05, Vol.7 (5), p.e564-e564

2017

Volltextzugriff (PDF)

Mutations and Treatment Outcome in Cytogenetically Normal Acute Myeloid Leukemia

The New England journal of medicine, 2008-05, Vol.358 (18), p.1909-1918

2008

Volltextzugriff (PDF)

Prospective Randomized Multicenter Study Comparing Cyclosporin Alone Versus the Combination of Antithymocyte Globulin and Cyclosporin for Treatment of Patients With Nonsevere Aplastic Anemia: A Report From the European Blood and Marrow Transplant (EBMT) Severe Aplastic Anaemia Working Party

Blood, 1999-04, Vol.93 (7), p.2191-2195

1999

Volltextzugriff (PDF)

Prospective Randomized Multicenter Study Comparing Cyclosporin Alone Versus the Combination of Antithymocyte Globulin and Cyclosporin for Treatment of Patients With Nonsevere Aplastic Anemia: A Report From the European Blood and Marrow Transplant (EBMT) Severe Aplastic Anaemia Working Party

Blood, 1999-04, Vol.93 (7), p.2191-2195

1999

Volltextzugriff (PDF)

Phase III Study of Second-Line Chemotherapy for Advanced Non–Small-Cell Lung Cancer With Weekly Compared With 3-Weekly Docetaxel

Journal of clinical oncology, 2005-11, Vol.23 (33), p.8389-8395

2005

Volltextzugriff (PDF)

A pathogenetic link between aplastic anemia and paroxysmal nocturnal hemoglobinuria is suggested by a high frequency of aplastic anemia patients with a deficiency of phosphatidylinositol glycan anchored proteins

Experimental hematology, 1995-01, Vol.23 (1), p.81-87

1995

Volltextzugriff (PDF)

Risk-adapted induction and consolidation therapy in adults with de novo AML aged </= 60 years: results of a prospective multicenter trial

Annals of hematology, 2004-06, Vol.83 (6), p.336-344

2004

Volltextzugriff (PDF)

Clonal Evolution and Blast Crisis Correlate with Enhanced Proteolytic Activity of Separase in BCR-ABL b3a2 Fusion Type CML under Imatinib Therapy

PloS one, 2015-06, Vol.10 (6), p.e0129648-e0129648

2015

Volltextzugriff (PDF)

Use of Polymerase Chain Reactions to Monitor Minimal Residual Disease in Acute Lymphoblastic Leukemia Patients

Blood, 1991-01, Vol.77 (2), p.331-339

1991

Volltextzugriff (PDF)

Evaluation of dose intensification of cytarabine in postremission therapy in older AML patients within the prospective phase II AMLSG 06-04 study

Annals of oncology, 2017-09, Vol.28, p.v366-v367

2017

Volltextzugriff (PDF)

Correction: High-risk additional chromosomal abnormalities at low blast counts herald death by CML

Leukemia, 2020-10, Vol.34 (10), p.2823-2823

2020

Volltextzugriff (PDF)

Prior and concurrent administration of recombinant human megakaryocyte growth and development factor in patients receiving consolidation chemotherapy for de novo acute myeloid leukemia: a randomized, placebo-controlled, double-blind safety and efficacy study

Annals of hematology, 2003-11, Vol.82 (11), p.677-683

2003

Volltextzugriff (PDF)

Graft rejection and second bone marrow transplants for acquired aplastic anaemia : a report from the aplastic anaemia working party of the European bone marrow transplant group

Bone marrow transplantation (Basingstoke), 1994-03, Vol.13 (3), p.233-237

1994

Volltextzugriff (PDF)

Tumor Necrosis Factor Induces Proliferation of Neoplastic B Cells From Chronic Lymphocytic Leukemia

Blood, 1989-04, Vol.73 (5), p.1242-1246

1989

Volltextzugriff (PDF)

Relapse of aplastic anaemia after immunosuppressive treatment: a report from the European Bone Marrow Transplantation Group SAA Working Party

British journal of haematology, 1993-10, Vol.85 (2), p.371-377

1993

Volltextzugriff (PDF)

High levels of thrombopoietin in sera of patients with essential thrombocythemia : Cause or consequence of abnormal platelet production?

Annals of hematology, 1998-11, Vol.77 (5), p.211-215

1998

Volltextzugriff (PDF)

Tumor necrosis factor induces proliferation of neoplastic B cells from chronic lymphocytic leukemia

Blood, 1989-04, Vol.73 (5), p.1242-1246

1989

Volltextzugriff (PDF)

Haemopoietic growth factors in aplastic anaemia: a cautionary note

The Lancet (British edition), 1994-07, Vol.344 (8916), p.172-173

1994

Volltextzugriff (PDF)

Serum erythropoietin and serum transferrin receptor levels in aplastic anaemia

British journal of haematology, 1994-10, Vol.88 (2), p.286-294

1994

Volltextzugriff (PDF)

Interleukin-5 is the predominant eosinophilopoietin produced by cloned T lymphocytes in hypereosinophilic syndrome

Experimental hematology, 1993-02, Vol.21 (2), p.358-365

1993

Volltextzugriff (PDF)

Prethymic phenotype and genotype of pre-T (CD7+/ER-)-cell leukemia and its clinical significance within adult acute lymphoblastic leukemia [see comments]

Blood, 1989-04, Vol.73 (5), p.1247-1258

1989

Volltextzugriff (PDF)

Association between structural and numerical chromosomal aberrations in acute myeloblastic leukemia: a study by RT-PCR and FISH in 447 patients with de-novo AML

Annals of hematology, 1999-06, Vol.78 (6), p.265-269

1999

Volltextzugriff (PDF)

Analyses of Phenotype and Genotype in Acute Lymphoblastic Leukemias at First Presentation and in Relapse

Blood, 1987-10, Vol.70 (4), p.1079-1083

1987

Volltextzugriff (PDF)

1 – 25 von 172

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(155)
Mit Volltextzugriff
(127)

Publikationsform

Sprache

Englisch
(167)
Japanisch
(11)
Deutsch
(5)

Erscheinungsjahr

n.n

Thema

Science & Technology
(82)
Humans
(81)
Life Sciences & Biomedicine
(66)
Biological And Medical Sciences
(60)
Medical Sciences
(53)
Male
(46)
Hematology
(45)
Adult
(44)
Female
(42)
Middle Aged
(35)
Hematologic And Hematopoietic Diseases
(32)
Adolescent
(24)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(23)
Aged
(22)
Anemia, Aplastic - Therapy
(15)
Oncology
(15)
Animals
(14)
Child
(12)
Antilymphocyte Serum - Therapeutic Use
(11)
Bone Marrow Transplantation
(11)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Impact of IDH1 R132 Mutations and an IDH1 Single Nucleotide Polymorphism in Cytogenetically Normal Acute Myeloid Leukemia: SNP rs11554137 Is an Adverse Prognostic Factor

Condensed versus standard schedule of high-dose cytarabine consolidation therapy with pegfilgrastim growth factor support in acute myeloid leukemia

Mutations and Treatment Outcome in Cytogenetically Normal Acute Myeloid Leukemia

High-risk additional chromosomal abnormalities at low blast counts herald death by CML

Prospective Randomized Multicenter Study Comparing Cyclosporin Alone Versus the Combination of Antithymocyte Globulin and Cyclosporin for Treatment of Patients With Nonsevere Aplastic Anemia: A Report From the European Blood and Marrow Transplant (EBMT) Severe Aplastic Anaemia Working Party

Prospective Randomized Multicenter Study Comparing Cyclosporin Alone Versus the Combination of Antithymocyte Globulin and Cyclosporin for Treatment of Patients With Nonsevere Aplastic Anemia: A Report From the European Blood and Marrow Transplant (EBMT) Severe Aplastic Anaemia Working Party

Phase III Study of Second-Line Chemotherapy for Advanced Non–Small-Cell Lung Cancer With Weekly Compared With 3-Weekly Docetaxel

A pathogenetic link between aplastic anemia and paroxysmal nocturnal hemoglobinuria is suggested by a high frequency of aplastic anemia patients with a deficiency of phosphatidylinositol glycan anchored proteins

Risk-adapted induction and consolidation therapy in adults with de novo AML aged </= 60 years: results of a prospective multicenter trial

Clonal Evolution and Blast Crisis Correlate with Enhanced Proteolytic Activity of Separase in BCR-ABL b3a2 Fusion Type CML under Imatinib Therapy

Use of Polymerase Chain Reactions to Monitor Minimal Residual Disease in Acute Lymphoblastic Leukemia Patients

Evaluation of dose intensification of cytarabine in postremission therapy in older AML patients within the prospective phase II AMLSG 06-04 study

Correction: High-risk additional chromosomal abnormalities at low blast counts herald death by CML

Prior and concurrent administration of recombinant human megakaryocyte growth and development factor in patients receiving consolidation chemotherapy for de novo acute myeloid leukemia: a randomized, placebo-controlled, double-blind safety and efficacy study

Graft rejection and second bone marrow transplants for acquired aplastic anaemia : a report from the aplastic anaemia working party of the European bone marrow transplant group

Tumor Necrosis Factor Induces Proliferation of Neoplastic B Cells From Chronic Lymphocytic Leukemia

Relapse of aplastic anaemia after immunosuppressive treatment: a report from the European Bone Marrow Transplantation Group SAA Working Party

High levels of thrombopoietin in sera of patients with essential thrombocythemia : Cause or consequence of abnormal platelet production?

Tumor necrosis factor induces proliferation of neoplastic B cells from chronic lymphocytic leukemia

Haemopoietic growth factors in aplastic anaemia: a cautionary note

Serum erythropoietin and serum transferrin receptor levels in aplastic anaemia

Interleukin-5 is the predominant eosinophilopoietin produced by cloned T lymphocytes in hypereosinophilic syndrome

Prethymic phenotype and genotype of pre-T (CD7+/ER-)-cell leukemia and its clinical significance within adult acute lymphoblastic leukemia [see comments]

Association between structural and numerical chromosomal aberrations in acute myeloblastic leukemia: a study by RT-PCR and FISH in 447 patients with de-novo AML

Analyses of Phenotype and Genotype in Acute Lymphoblastic Leukemias at First Presentation and in Relapse

Suchergebnisse filtern